Smad7: a new key player in TGF-β-associated disease
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 8 (8) , 361-363
- https://doi.org/10.1016/s1471-4914(02)02376-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 20 references indexed in Scilit:
- RETRACTED: Deficient Smad7 expression: A putative molecular defect in sclerodermaProceedings of the National Academy of Sciences, 2002
- Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel diseaseJournal of Clinical Investigation, 2001
- Efficient TGF-β Induction of the Smad7 Gene Requires Cooperation between AP-1, Sp1, and Smad Proteins on the Mouse Smad7 PromoterJournal of Biological Chemistry, 2000
- Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (Tgf)-β1 PlasmidThe Journal of Experimental Medicine, 2000
- Transforming growth factor β-inducible independent binding of SMAD to the Smad7 promoterProceedings of the National Academy of Sciences, 2000
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Smad3 and Smad4 Mediate Transcriptional Activation of the Human Smad7 Promoter by Transforming Growth Factor βJournal of Biological Chemistry, 2000
- Regulation of Smad ActivityCell, 2000
- The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ SignalingCell, 1997
- Transforming growth factor beta: the good, the bad, and the ugly.The Journal of Experimental Medicine, 1994